Today in Healthcare: Prime and Synchrony Expand Relationship; Online Billing Helps Senior Living; Anomaly Grabs $17M
Today in healthcare, 23andMe buys Lemonaid Health for $400 million, and Prime and Synchrony expand healthcare financing offering. Plus, online billing makes things easier for senior living facilities operators and their residents, and Anomaly snags $17 million in Series A and seed funding.
Healthcare Payments Platform Anomaly Raises $17M
Healthcare payments platform Anomaly announced on Tuesday (Oct. 26) that it has raised $17 million in Series A and seed funding that will allow the company to expand its team and its market presence and to invest in product development.
The funding round was led by RRE Ventures, with participation from Link Ventures and existing investors Madrona Venture Group, Declaration Partners and Redesign Health.
Prime Healthcare Expands Healthcare Financing With Synchrony Collaboration
Healthcare provider Prime Healthcare and financial service company Synchrony expanded their partnership on Tuesday (Oct. 26) by giving Prime patients at 45 hospitals in 14 states the ability to pay for their healthcare over time through Synchrony’s CareCredit credit card.
Members can apply for the Synchrony CareCredit card on their mobile devices, computers, in their provider’s office or over the phone, then can pay bills in long- and short-term chunks immediately upon getting their cards.
Online Billing Brings Payments Relief To Senior Living Facilities, Residents
A new poll from the AARP revealed most Americans prefer to grow old in their own homes with medical aid rather than at a hospital or senior living facility at a time when all baby boomers will be at least 65 by 2030.
According to PYMNTS’ Long-Term Care And Payments Report, 10% of older adults have plans for future long-term care necessities. While 48% of financial advisers claim to have spoken with their clients about senior living costs, just 38% of clients say their financial advisers have reviewed any policies with them.
23andMe to Buy Web Platform Lemonaid Health for $400M
DNA genealogy platform 23andMe will buy web-based healthcare platform Lemonaid Health for $400 million.
Lemonaid Health offers online access to healthcare from consultation through treatment. 23andMe CEO and co-founder Anne Wojcicki says the Lemonaid acquisition is about “taking an important step in transforming the traditional primary care experience and making personalized healthcare a reality.”